BridgeBio Oncology Therapeutics, Inc. (BBOT) stock news · $610.4M cap
BridgeBio Oncology Therapeutics, Inc. (BBOT) is a biotechnology company listed on NASDAQ.
This BBOT news page leads with what BridgeBio Oncology Therapeutics, Inc. filed — not a scraped headline mill.
No cached 8-K sentence for BBOT yet. We will not pad this page with generic market recap.
Latest reported BBOT revenue for 2026-06-30 was $3.6M. Net income was -$56.5M. Revenue was down 10.0% from 2026-03-31 to 2026-06-30. BBOT currently screens at market cap $610.4M.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the BBOT stock page; for the tape open the quote page.
BBOT stock news FAQ
What are BBOT's latest revenue and net income?
Latest cached BridgeBio Oncology Therapeutics, Inc. (BBOT) revenue for Jun 30, 2026 was $3.6M. Net income was -$56.5M. Statements: https://lician.com/financials/bbot
How did BBOT revenue change from the prior cached period?
Cached BridgeBio Oncology Therapeutics, Inc. (BBOT) revenue was down 10.0% from $3.9M (Mar 31, 2026) to $3.6M (Jun 30, 2026). Statements: https://lician.com/financials/bbot
What is BBOT's market cap?
BridgeBio Oncology Therapeutics, Inc. (BBOT) market cap is $610.4M on the latest cached fundamentals snapshot.
What kind of company is BBOT?
BridgeBio Oncology Therapeutics, Inc. (BBOT) is a biotechnology company listed on NASDAQ.
Where is BBOT stock news listed?
Cached stock news for BridgeBio Oncology Therapeutics, Inc. (BBOT) is listed at https://lician.com/news/bbot. Filings: https://lician.com/sec/bbot
Not investment advice.